Magnitude of multiple drug use and determinants of vulnerability among chronic kidney disease inpatients in Ethiopia: a multi-center study

Tirsit Ketsela Zeleke,Rahel Belete Abebe,Samuel Agegnew Wondm,Bantayehu Addis Tegegne
DOI: https://doi.org/10.1186/s12882-024-03773-x
2024-10-10
BMC Nephrology
Abstract:Patients with chronic kidney disease frequently face various nutritional and metabolic problems that necessitate the use of multiple medications. This multiple drug use can lead to several drug-related problems including adverse drug events, hospital admissions, poor medication adherence, harmful drug interactions, inadequate therapeutic outcomes, and death. Despite these challenges, there is a notable lack of studies on the extent of multiple drug use and its determinants among patients with chronic kidney disease in Ethiopia. This study aims to assess the magnitude of multiple drug use and identify the determinants of vulnerability among patients with chronic kidney disease in Ethiopia.
urology & nephrology
What problem does this paper attempt to address?